Literature DB >> 26622610

RhoC is essential in TGF-β1 induced epithelial-mesenchymal transition in cervical cancer cells.

Xiaoqi He1, Ying Qian1, Huilan Cai1, Shouhua Yang1, Jing Cai1, Zehua Wang1.   

Abstract

Epithelial-mesenchymal transition (EMT) is a critical process in the promotion of epithelial tumor progression and metastasis. The present study aimed to investigate the role of Ras homolog gene family, member C (RhoC) guanosine triphosphatase (GTPase) in transforming growth factor (TGF)-β1 induced EMT. EMT occurred in human cervical carcinoma SiHa cells following TGF-β1 stimulation for 4 days, as demonstrated by the appearance of mesenchymal morphology, reorganization of the actin cytoskeleton, reduced E-cadherin expression and increased Vimentin expression, which was associated with increased RhoC expression and activity. However, EMT was not observed in cells that were pretreated with RhoC siRNA prior to TGF-β1 stimulation. Downregulation of RhoC 4 days following TGF-β1 stimulation was not able to reverse the existing EMT. In addition, TGF-β1 promoted the invasion of the control SiHa cells but not that of the cells in which RhoC was downregulated. In conclusion, RhoC expression is activated by TGF-β1, and sufficient RhoC expression levels are essential for TGF-β1-induced EMT.

Entities:  

Keywords:  RNA interference; Ras homolog gene family; cervical cancer; epithelial-mesenchymal transition; invasion; member C guanosine triphosphatase

Year:  2015        PMID: 26622610      PMCID: PMC4509456          DOI: 10.3892/ol.2015.3287

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  21 in total

Review 1.  Epithelial-mesenchymal transitions in development and disease.

Authors:  Jean Paul Thiery; Hervé Acloque; Ruby Y J Huang; M Angela Nieto
Journal:  Cell       Date:  2009-11-25       Impact factor: 41.582

2.  Epithelial-mesenchymal Transition---A Hallmark of Breast Cancer Metastasis.

Authors:  Yifan Wang; Binhua P Zhou
Journal:  Cancer Hallm       Date:  2013-03

3.  A transient, EMT-linked loss of basement membranes indicates metastasis and poor survival in colorectal cancer.

Authors:  Simone Spaderna; Otto Schmalhofer; Falk Hlubek; Geert Berx; Andreas Eger; Susanne Merkel; Andreas Jung; Thomas Kirchner; Thomas Brabletz
Journal:  Gastroenterology       Date:  2006-09       Impact factor: 22.682

4.  Transforming growth factor-beta-induced mobilization of actin cytoskeleton requires signaling by small GTPases Cdc42 and RhoA.

Authors:  Sofia Edlund; Maréne Landström; Carl-Henrik Heldin; Pontus Aspenström
Journal:  Mol Biol Cell       Date:  2002-03       Impact factor: 4.138

5.  Functional analysis of the contribution of RhoA and RhoC GTPases to invasive breast carcinoma.

Authors:  Kaylene J Simpson; Aisling S Dugan; Arthur M Mercurio
Journal:  Cancer Res       Date:  2004-12-01       Impact factor: 12.701

Review 6.  Epithelial-mesenchymal transition and tumour invasion.

Authors:  Marcello Guarino
Journal:  Int J Biochem Cell Biol       Date:  2007-07-31       Impact factor: 5.085

7.  Loss of Smad4 correlates with loss of the invasion suppressor E-cadherin in advanced colorectal carcinomas.

Authors:  Anke Reinacher-Schick; Stephan E Baldus; Bashra Romdhana; Stephanie Landsberg; Marc Zapatka; Stefan P Mönig; Arnulf H Hölscher; Hans P Dienes; Wolff Schmiegel; Irmgard Schwarte-Waldhoff
Journal:  J Pathol       Date:  2004-04       Impact factor: 7.996

8.  Rho activation is required for transforming growth factor-beta-induced epithelial-mesenchymal transition in lens epithelial cells.

Authors:  Hee Jun Cho; Jiyun Yoo
Journal:  Cell Biol Int       Date:  2007-04-25       Impact factor: 3.612

9.  Transforming growth factor-β-induced epithelial-mesenchymal transition facilitates epidermal growth factor-dependent breast cancer progression.

Authors:  M K Wendt; J A Smith; W P Schiemann
Journal:  Oncogene       Date:  2010-08-30       Impact factor: 9.867

Review 10.  Role of epithelial-mesenchymal transition in pancreatic ductal adenocarcinoma: is tumor budding the missing link?

Authors:  Eva Karamitopoulou
Journal:  Front Oncol       Date:  2013-09-17       Impact factor: 6.244

View more
  5 in total

1.  Effect of RhoC on the epithelial-mesenchymal transition process induced by TGF-β1 in lung adenocarcinoma cells.

Authors:  Xiaoxiao Lu; Honglan Guo; Xi Chen; Jian Xiao; Yong Zou; Wei Wang; Qiong Chen
Journal:  Oncol Rep       Date:  2016-10-04       Impact factor: 3.906

Review 2.  Cancer Stem Cells and Radioresistance: Rho/ROCK Pathway Plea Attention.

Authors:  Annapurna Pranatharthi; Cecil Ross; Sweta Srivastava
Journal:  Stem Cells Int       Date:  2016-08-15       Impact factor: 5.443

3.  Inhibitor of β-catenin and TCF (ICAT) promotes cervical cancer growth and metastasis by disrupting E-cadherin/β-catenin complex.

Authors:  Yayun Jiang; Wei Ren; Weijia Wang; Jing Xia; Liyao Gou; Mengyao Liu; Qun Wan; Lan Zhou; Yaguang Weng; Tongchuan He; Yan Zhang
Journal:  Oncol Rep       Date:  2017-09-18       Impact factor: 3.906

4.  Enhanced efficacy with reduced toxicity of chemotherapy drug 5-fluorouracil by synergistic treatment with Abnormal Savda Munziq from Uyghur medicine.

Authors:  Tao Yang; Mutalifu Aimaiti; Deqi Su; Weiwei Miao; Bin Zhou; Dilinuer Maimaitiyiming; Abdiryim Yusup; Halmurat Upur; Ainiwaer Aikemu
Journal:  BMC Complement Altern Med       Date:  2017-04-07       Impact factor: 3.659

5.  Discriminating high-risk cervical Human Papilloma Virus infections with urinary biomarkers via non-targeted GC-MS-based metabolomics.

Authors:  Filipa Godoy-Vitorino; Gilmary Ortiz-Morales; Josefina Romaguera; Maria M Sanchez; Magaly Martinez-Ferrer; Natalyia Chorna
Journal:  PLoS One       Date:  2018-12-28       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.